nfr-logonfr-logo
PROSJEKTBANKEN
Switch to English
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

FRIMEDBIO-Fri prosj.st. med.,helse,biol

New diagnostic markers and targets for therapeutic intervention in B-cell lymphoma

Lymfekreft er den vanligste formen for kreft i blod- og lymfesystemet. Sykdommen kan deles inn i mange undergrupper som har ulik prognose og som krever ulik behandling. Diffust storcellet B-celle lymfom (DLBCL) er den mest vanlige formen for aggressiv lymfekreft, mens follikulært lymfom (FL) er d...

Tildelt: kr 8,3 mill.

Prosjektperiode: 2014-2018

Sted: Oslo

FRIMEDBIO-Fri prosj.st. med.,helse,biol

Molecular characterization and functional studies of human B cell lymphoma

Malignant lymphomas represent a heterogeneous group of diseases with variable clinical course. Our group aims at identifying genes/signalling pathways with prognostic, diagnostic or therapeutic potential in B cell lymphomas. We are one of 7 groups that co nstitute the newly established Centre for...

Tildelt: kr 3,2 mill.

Prosjektperiode: 2008-2013

Sted: Oslo

FRIMEDBIO-Fri prosj.st. med.,helse,biol

Studies of growth control and gene expression in normal and neoplastic B-lymphoid cells

Malignant lymphomas represent a heterogeneous group of diseases with variable clinical course. The complex biology and the variety of genetic and epigenetic factors involved in the pathogenesis make lymphomas a challenging disease for translational resear ch. There a clear need for the developmen...

Tildelt: kr 2,3 mill.

Prosjektperiode: 2006-2012

Sted: Oslo

MILJO-Miljøstøtte

Strategies for molecular characterisation of human B-cell lymphomas. Diagnostic and therapeutical potential

...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2003-2007

Sted: Oslo

1